Afrin nasal
Selected indexed studies
- Rosacea management: A comprehensive review. (J Cosmet Dermatol, 2022) [PMID:35104917]
- Epistaxis: Outpatient Management. (Am Fam Physician, 2018) [PMID:30215971]
- Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options. (J Cosmet Dermatol, 2021) [PMID:34378298]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Oxymetazoline nasal spray. (1998) pubmed
- Epistaxis: Outpatient Management. (2018) pubmed
- Rosacea management: A comprehensive review. (2022) pubmed
- Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options. (2021) pubmed
- Common cold. (2008) pubmed
- Oxymetazoline (Afrin®): maybe there is more that we need to know. (2014) pubmed
- Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method. (2010) pubmed
- Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray. (1983) pubmed
- Afrin and other nasal decongestant drugs. (1965) pubmed
- Evaluation of a nasal decongestant. Oxymetazoline hydrochloride (Afrin). (1965) pubmed